Stephen Berenson - Profile and Investment Details

Investor Profile

Stephen Berenson is a Venture Capital, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Denali Therapeutics, Sail Biomedicines, Syros Pharmaceuticals, Incredible Foods, Inzen Therapeutics, Ohana Biosciences, T2 Biosystems, Tangent Medical Technologies, Kaleido BioSciences, Permeon Biologics, Kovio, Oasys Water, Editas Medicine, Tessera TherapeuticsRing Therapeutics, Moderna Therapeutics, Omega Therapeutics, Cygnal Therapeutics, Sana Biotechnology, Seres Therapeutics, Agios Pharmaceuticals, Red Rock Biofuels, Tarveda Therapeutics, Receptos, Repertoire Immune Medicines, Generate Biomedicines, Codiak Biosciences, BlackDuck, Polatis, Seventh Sense Biosystems, Sigilon Therapeutics, Boragen, TARIS Biomedical, TransMedics, Selecta Biosciences, Quanterix, Visterra, Sesen Bio, Inc., CiBO Technologies, medidametrics, Rubius Therapeutics, Axcella, Senda Biosciences, Foghorn Therapeutics, Evelo Biosciences, Inari, Joule Unlimited Technologies, Cellarity, WikiCell Designs, Avedro, Indigo, EcoSense Lighting, J.P. Morgan, Valo Health, Invaio Sciences, . Over time, Stephen Berenson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Stephen Berenson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Creative Venture, Clean Tech, Health Care, Research and Development, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Healthcare Innovation, Strategic Partnerships, Life Science, Engineering, Science, Venture Fundraising, Biotechnology, Medical Devices, Drug Development, Hispanic / Latinx Founded, Clean Technology, Entrepreneurship, Innovation, Clinical Trials, Groceries, Disruptive technology, Research, Agriculture, Personalized Medicine, Oil and Gas, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Health Tech, Machine Learning, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Stephen Berenson, as their portfolio suggests a familiarity and interest in this area.

Understanding Stephen Berenson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.